3/2
09:04 am
dftx
Definium Therapeutics (DFTX) had its price target raised by HC Wainwright from $55.00 to $70.00. They now have a "buy" rating on the stock.
Low
Report
Definium Therapeutics (DFTX) had its price target raised by HC Wainwright from $55.00 to $70.00. They now have a "buy" rating on the stock.
2/28
03:23 pm
dftx
Definium Therapeutics Weighs Breakthrough Status Against Valuation And Trial Risks [Yahoo! Finance]
Low
Report
Definium Therapeutics Weighs Breakthrough Status Against Valuation And Trial Risks [Yahoo! Finance]
2/26
11:40 pm
dftx
Definium Therapeutics Q4 Earnings Call Highlights [Yahoo! Finance]
Low
Report
Definium Therapeutics Q4 Earnings Call Highlights [Yahoo! Finance]
2/26
04:14 pm
dftx
Definium Therapeutics Reports Full-Year 2025 Financial Results and Business Updates [Yahoo! Finance]
Low
Report
Definium Therapeutics Reports Full-Year 2025 Financial Results and Business Updates [Yahoo! Finance]
2/26
04:01 pm
dftx
Definium Therapeutics Reports Full-Year 2025 Financial Results and Business Updates
Low
Report
Definium Therapeutics Reports Full-Year 2025 Financial Results and Business Updates
2/25
06:24 am
dftx
Definium Therapeutics (DFTX) was upgraded by Wolfe Research to "strong-buy".
Low
Report
Definium Therapeutics (DFTX) was upgraded by Wolfe Research to "strong-buy".
2/24
07:21 am
dftx
Definium Therapeutics to Participate at Upcoming Investor Conferences [Yahoo! Finance]
Low
Report
Definium Therapeutics to Participate at Upcoming Investor Conferences [Yahoo! Finance]
2/24
07:01 am
dftx
Definium Therapeutics to Participate at Upcoming Investor Conferences
Low
Report
Definium Therapeutics to Participate at Upcoming Investor Conferences
2/26/2026
04:01 pm
dftx
definium therapeutics, inc. - common shares
MISS
Report
0.9%
definium therapeutics, inc. - common shares
2/26
04:25 pm
dftx
Form 10-K Definium Therapeutics, For: Dec 31
Low
Report
Form 10-K Definium Therapeutics, For: Dec 31
2/26
04:15 pm
dftx
Form 8-K Definium Therapeutics, For: Feb 26
Low
Report
Form 8-K Definium Therapeutics, For: Feb 26
2/17
04:22 pm
dftx
Form SCHEDULE 13G/A Definium Therapeutics, Filed by: Commodore Capital LP
Low
Report
Form SCHEDULE 13G/A Definium Therapeutics, Filed by: Commodore Capital LP
2/17
09:22 am
dftx
Form SCHEDULE 13G Definium Therapeutics, Filed by: DRIEHAUS CAPITAL MANAGEMENT LLC
Medium
Report
Form SCHEDULE 13G Definium Therapeutics, Filed by: DRIEHAUS CAPITAL MANAGEMENT LLC
2/17
09:01 am
dftx
Form SCHEDULE 13G Definium Therapeutics, Filed by: Avoro Capital Advisors LLC
Medium
Report
Form SCHEDULE 13G Definium Therapeutics, Filed by: Avoro Capital Advisors LLC
2/13
08:43 am
dftx
Form SCHEDULE 13G/A Definium Therapeutics, Filed by: Deep Track Capital, LP
Low
Report
Form SCHEDULE 13G/A Definium Therapeutics, Filed by: Deep Track Capital, LP
2/5
05:01 pm
dftx
Form 4 Definium Therapeutics, For: Feb 03 Filed by: Wiley Matthew T.
Medium
Report
Form 4 Definium Therapeutics, For: Feb 03 Filed by: Wiley Matthew T.
2/5
04:57 pm
dftx
Form 4 Definium Therapeutics, For: Feb 03 Filed by: Roberts Brandi
Medium
Report
Form 4 Definium Therapeutics, For: Feb 03 Filed by: Roberts Brandi
News Stats
All News
News Wires
Media Monitoring
SEC Edgar Filings
Upgrades
Downgrades
Initiated
Reiterated
Last Earnings
Last Earnings EPS
Next Earnings
Order Stats
Sub-Penny
Odd lot
Avg. bid-ask spread
Avg. bid-ask size
Shares at ask/bid
Off exchange
Main News & Impact Reports
Don’t Miss Out On The Next BIG Stock Move
Never get left behind with our daily ‘Shakers & Movers’ newsletter. Discover the biggest gainer or loser in the stock market, and learn exactly WHY it moved. To find out which one caught Wall Street by surprise TODAY, sign up to our newsletter below:
Register